Lymphome non hodgkinien primitif du foie: à propos d'un cas et revue de la littérature

Ammar, C. Nasr Ben; Chaari, Néila; Kochbati, L.; Besbes, M.; Maalej, M

doi:10.1016/j.canrad.2006.09.117

Cited by 5 publications

(6 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Previous studies have reported the use of surgical resection, radiotherapy and chemotherapy as treatment modalities for PHL, alone or in combination (16–18). For low-volume localized PHL, surgical resection may be an effective treatment option, alone or in combination with chemotherapy (1,19,20).…”

Section: Discussionmentioning

confidence: 99%

Complete response to comprehensive treatment of a primary hepatic diffuse large B cell lymphoma: A case report

Zhang

Chen

et al. 2015

Oncology Letters

View full text Add to dashboard Cite

Primary hepatic lymphoma (PHL) is an uncommon lymphoid tumor with varied clinical features and treatment outcome. In the present study, the case of a 56-year-old patient with PHL and no clinical presentation was reported. During a routine physical examination, multiple hypodense nodules were incidentally detected in right lobes of the liver and hepatic portal in an abdominal computed tomography scan. A liver biopsy revealed the presence of a non-Hodgkin’s lymphoma diffuse large B cell type that was CD20-positive, followed by the diagnosis of a PHL. The patient was treated with R-CHOP, radiotherapy and R-Hyper-CVAD/R-HD MTX-ara-C, and complete remission was achieved.

show abstract

Section: Discussionmentioning

confidence: 99%

Complete response to comprehensive treatment of a primary hepatic diffuse large B cell lymphoma: A case report

Zhang

Chen

et al. 2015

Oncology Letters

View full text Add to dashboard Cite

show abstract

“…As far as the role of surgery in PHL is concerned, there are studies that report better outcomes in terms of survival in patients treated with surgery and postoperative chemotherapy for PHL [15] , [16] , [17] . In our case, surgery was performed because the patient was confused about the interpretation of the imaging findings and considered surgery as the optimal treatment.…”

Section: Discussionmentioning

confidence: 99%

Primary hepatic mucosa-associated lymphoid tissue lymphoma in a patient with no chronic liver disease: Case report

Betianu¹,

Dima²,

Pavaloiu³

2017

Radiology Case Reports

View full text Add to dashboard Cite

Extramarginal zone lymphoma of mucosa-associated lymphoid tissue (MALT) is a non-Hodgkin lymphoma of low-grade malignancy. The most common localization is the stomach, and the common nongastric sites are salivary glands, the skin, orbits, the conjunctiva, the lung, breasts, upper airways, other gastrointestinal sites, and the liver. Primary hepatic MALT lymphoma is a rare disease and the diagnostic can be challenging. The clinical presentation is nonspecific and may range from no symptoms to end-stage liver disease. The radiological aspect of hepatic lymphoma may indicate this diagnosis; however, the final diagnosis is made by hepatic biopsy. We report the case of a 47-year-old woman with no chronic liver disease, incidentally found with a focal liver mass at ultrasound examination. The only clinical symptom was fatigue. The blood tests were normal and tumoral markers were negative. Computed tomography and magnetic resonance imaging were performed. However, because the hepatic lesion was first described as a benign entity and, at second opinion, the suspicion of lymphoma was raised, the patient decided to undergo surgery first, without prior biopsy. The histopathologic analysis confirmed the diagnosis: hepatic MALT lymphoma positive for CD 20 and negative for CD 5, BCL6, cyclin D1, and CD 23. No lymph node involvement was noted and follow-up imaging with positron emission tomography-computed tomography did not show any other site of disease, thus confirming the diagnosis of primary hepatic MALT lymphoma. The aim of this paper was to highlight the imagistic features of primary hepatic lymphoma to contribute to the early diagnosis of this rare disease entity.

show abstract

Section: Discussionmentioning

confidence: 99%

“…The therapeutic modalities reported in the literature are variable associating surgery, chemotherapy, radiotherapy, or combination of the various processes [ 2 , 3 ]. However, early surgical treatment followed by chemotherapy seems to give good performances and provide benefits in term of survival [ 6 , 16 ]. The indications for surgery are not well established, although localized disease can be treated by liver resection [ 16 ].…”

Section: Discussionmentioning

confidence: 99%

“…However, early surgical treatment followed by chemotherapy seems to give good performances and provide benefits in term of survival [ 6 , 16 ]. The indications for surgery are not well established, although localized disease can be treated by liver resection [ 16 ]. But it requires patients in good general condition in absence of co-morbidities, with preserved liver function and a tumor of small size [ 3 ].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Primary Hepatic Lymphoma

Zentar

Tarchouli

Elkaoui

et al. 2013

J Gastrointest Canc

View full text Add to dashboard Cite

Lymphome non hodgkinien primitif du foie: à propos d'un cas et revue de la littérature

Cited by 5 publications

References 17 publications

Complete response to comprehensive treatment of a primary hepatic diffuse large B cell lymphoma: A case report

Complete response to comprehensive treatment of a primary hepatic diffuse large B cell lymphoma: A case report

Primary hepatic mucosa-associated lymphoid tissue lymphoma in a patient with no chronic liver disease: Case report

Primary Hepatic Lymphoma

Contact Info

Product

Resources

About